WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke LASANTH wurde als Wortmarke am 02.04.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1610291 |
| Länder | 
|
| Basismarke |
Nr. 90236132,
05. Oktober 2020
|
| Anmeldedatum | 02. April 2021 |
| Ablaufdatum | 02. April 2031 |
Markeninhaber
48 Holland Brook Road
Whitehouse Station NJ 08889
US
Whitehouse Station NJ 08889
US
Markenvertreter
1299 Pennsylvania Avenue, Suite 700
Washington DC 20004
US
Waren und Dienstleistungen
35
Business consulting services in the field of regulatory and
corporate compliance; business development services;
business strategy development services; business consulting
and management in the field of clinical trials, namely,
clinical data and regulatory submission management on behalf
of medical, pharmaceutical, biopharmaceutical and
biotechnology companies to assist them with clinical
research, clinical trials and applications for drug
approval; regulatory submission management, namely,
assisting others in preparing and filing applications for
new medical devices, medical technologies, medications,
pharmaceutical, biopharmaceuticals, and biotechnology with
governmental regulatory bodies around the world; regulatory
submission management, namely, providing simultaneous
multiple country submissions of applications for the
registration and approval of medical devices, medical
technologies, medications, pharmaceutical,
biopharmaceuticals, and biotechnology; providing business
information online regarding regulatory submission
management; business management consulting, strategic
planning and business advisory services provided to medical,
medical technology, pharmaceutical, biopharmaceutical, and
biotechnology companies, and government agencies,
educational and research institutions, law firms, and
investment firms in the fields of biologics, pharmaceuticals
and medical devices; providing consulting services in the
field of regulatory submission management to medical
companies to assist them with applications for drug and
medical device approval; regulatory submission management,
namely, assisting others in preparing and filing
applications for new drugs and medical devices with
governmental regulatory bodies; business consulting services
in the field of biologics, pharmaceuticals, prescription
drugs and medical devices
42
Consulting services for others in the field of designing
pre-clinical and clinical studies and trials for others;
product research and development for others in the fields of
biologics, pharmaceuticals, prescription drugs and medical
devices; quality management services, namely, quality
evaluation and analysis, quality assurance and quality
control in the field of biologics, pharmaceuticals,
prescription drugs and medical devices; scientific
consulting and research services relating to the field of
pharmaceuticals, medical devices, and life sciences, namely,
biology, and medicine; consulting services in the fields of
biotechnology and pharmaceuticals, namely, design,
development, technical verification and technical validation
of manufacturing and filling processes, drug formulations,
testing protocols and analytical methods; and scientific and
technological services, namely, scientific research,
analysis, testing, and related scientific studies in the
field of chemistry and molecular biology, namely, biologics
and protein detection, characterization, analysis and
testing; consulting services in the field of product quality
approval for medical devices for commercial purposes
45
Regulatory compliance consulting services, namely, reviewing
standards and practices to assist clients with compliance
with governmental laws, regulations and rules in the fields
of medical devices, medical technologies, medications,
biopharmaceuticals, and biotechnology; providing technical
regulatory affair consulting services directed to medical,
medical technology, biopharmaceutical, and biotechnology
companies in order to assure compliance with food and drug
administration's laws and regulations; provision of
information online pertaining to regulatory compliance in
the fields of medical devices, medical technologies,
medications, biopharmaceuticals, and biotechnology; and
regulatory compliance consulting in the fields of biologics,
pharmaceuticals, prescription drugs and medical devices
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 23. März 2023 | 2023/13 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. Februar 2023 | 2023/8 Gaz | JP | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 17. Oktober 2022 | 2022/42 Gaz | KR | Ablehnung |
| 01. September 2022 | 2022/40 Gaz | RAW: Limitation | |
| 02. Juni 2022 | 2022/22 Gaz | JP | Ablehnung |
| 02. Mai 2022 | 2022/19 Gaz | IL | Ablehnung |
| 15. Februar 2022 | 2022/7 Gaz | IN | Ablehnung |
| 19. Januar 2022 | 2022/3 Gaz | EM | Ablehnung |
| 05. Januar 2022 | 2022/1 Gaz | GB | Ablehnung |
| 04. Januar 2022 | 2022/1 Gaz | CN | Ablehnung |
| 02. April 2021 | 2021/33 Gaz | US | Eintragung |
ID: 141610291